You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (311)

Journals (0)

1-10 of 311 results for PD-L1 inhibitors

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Therapeutic and Systemic Adverse Events of Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 axis for Clinical Management of NSCLC

Open access

Review article

First published 2021

Therapeutic and Systemic Adverse Events of Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 axis for Clinical Management of NSCLC

Jing Chen, Yaser Alduais, Baoan Chen

Cell Transplantation

Select article: Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer

Open access

Research article

First published 2020

Association of immune-related pneumonitis with the efficacy of PD-1/PD-L1 inhibitors in non-small cell lung cancer

Pengfei Cui, Di Huang, Zhaozhen Wu [...]

Therapeutic Advances in Medical Oncology

Select article: Retrospective analysis of immune-related adverse events of the immune checkpoint inhibitors of PD-1/PD-l1 in the Fujian provincial hospital

Open access

Research article

First published 2022-04

Retrospective analysis of immune-related adverse events of the immune checkpoint inhibitors of PD-1/PD-l1 in the Fujian provincial hospital

Jianping Zheng, Tongjian Cui, Yu Gao [...]

European Journal of Inflammation

Select article: Real-world efficacy of PD-1/PD-L1 inhibitors in patients with advanced pulmonary neuroendocrine carcinoma: a single-center analysis

Open access

Research article

First published 2024

Real-world efficacy of PD-1/PD-L1 inhibitors in patients with advanced pulmonary neuroendocrine carcinoma: a single-center analysis

Wanchen Zhai, Ying Yu, Haicheng Wu [...]

Therapeutic Advances in Medical Oncology

Select article: Advanced anaplastic thyroid carcinoma with positive expression of PD-L1 response to immune checkpoint inhibitors: A case report

Open access

Case report

First published 2025

Advanced anaplastic thyroid carcinoma with positive expression of PD-L1 response to immune checkpoint inhibitors: A case report

Shanmin Fan, Yang Yuan, Yanfang Su [...]

Sage Open Medical Case Reports

Select article: Therapeutic Approaches With Immune Checkpoint Inhibitors in Head and Neck Cancers and the Role of PD-L1 as a Biomarker

Open access

Article commentary

First published 2021-1

Therapeutic Approaches With Immune Checkpoint Inhibitors in Head and Neck Cancers and the Role of PD-L1 as a Biomarker

Karima Oualla, Luis Castelo Branco, Lamiae Nouiyakh [...]

Cancer Control

Select article: Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study

Open access

Research article

First published 2024

Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study

Qi Yuan, Chunhua Xu, Wei Wang [...]

Technology in Cancer Research & Treatment

Select article: Comparison of the profiles of first-line PD-1/PD-L1 inhibitors for advanced NSCLC lacking driver gene mutations: a systematic review and Bayesian network meta-analysis

Open access

Research article

First published 2023

Comparison of the profiles of first-line PD-1/PD-L1 inhibitors for advanced NSCLC lacking driver gene mutations: a systematic review and Bayesian network meta-analysis

Fu Wenfan, Xu Manman, Shi Xingyuan [...]

Sage Open Chronic Disease

Select article: Unlocking Benzosampangine’s Potential: A Computational Approach to Investigating,Its Role as a PD-L1 Inhibitor in Tumor Immune Evasion via Molecular Docking,Dynamic Simulation,and ADMET Profiling

Open access

Research article

First published 2024

Unlocking Benzosampangine’s Potential: A Computational Approach to Investigating,Its Role as a PD-L1 Inhibitor in Tumor Immune Evasion via Molecular Docking,Dynamic Simulation,and ADMET Profiling

Abderrahim Ait Ouchaoui, Salah Eddine El Hadad, Marouane Aherkou [...]

Bioinformatics and Biology Insights

Select article: Is Weak Acid Beneficial for Addressing Checkpoint Inhibitor–Triggered Cancer Hyper Progression in Anti-PD1/PD-L1 Immunotherapies?

Open access

Research article

First published 2020-7

Is Weak Acid Beneficial for Addressing Checkpoint Inhibitor–Triggered Cancer Hyper Progression in Anti-PD1/PD-L1 Immunotherapies?

Yulin Wan, Shanshan An, Yanchao Zhou [...]

Cancer Control

1
2
3
•••
32
10 / page

Article type

Publication date

Subjects

Access